🇺🇸 FDA
Pipeline program

relacorilant, CORT125134, Abraxane 5 mg/ml powder for dispersion for infusion.

CORT125134-556

Phase 3 small_molecule active

Quick answer

relacorilant, CORT125134, Abraxane 5 mg/ml powder for dispersion for infusion. for Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer is a Phase 3 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials